Inotiv, Inc. (NOTV)
USD 3.95
(-28.83%)
USD 3.95
(-28.83%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -105.14 Million USD | 68.83% |
| 2022 | -337.26 Million USD | -3195.57% |
| 2021 | 10.89 Million USD | 332.55% |
| 2020 | -4.68 Million USD | -493.04% |
| 2019 | -790 Thousand USD | -307.22% |
| 2018 | -194 Thousand USD | -121.95% |
| 2017 | 884 Thousand USD | 127.37% |
| 2016 | -3.23 Million USD | -396.6% |
| 2015 | 1.08 Million USD | 201.78% |
| 2014 | -1.07 Million USD | -238.42% |
| 2013 | 773 Thousand USD | 112.1% |
| 2012 | -6.39 Million USD | -1276.8% |
| 2011 | 543 Thousand USD | 120.18% |
| 2010 | -2.69 Million USD | 50.74% |
| 2009 | -5.46 Million USD | -266.89% |
| 2008 | -1.48 Million USD | -260.8% |
| 2007 | 926 Thousand USD | 135.48% |
| 2006 | -2.6 Million USD | -2484.15% |
| 2005 | -100.99 Thousand USD | 50.25% |
| 2004 | -203 Thousand USD | -332.52% |
| 2003 | 87.3 Thousand USD | -91.81% |
| 2002 | 1.06 Million USD | -39.64% |
| 2001 | 1.76 Million USD | 227.84% |
| 2000 | -1.38 Million USD | -330.34% |
| 1999 | 600 Thousand USD | 50.0% |
| 1998 | 400 Thousand USD | -42.86% |
| 1997 | 700 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -48.07 Million USD | -212.44% |
| 2024 Q3 | -26.08 Million USD | 45.74% |
| 2024 Q1 | -15.38 Million USD | -59.25% |
| 2023 Q2 | -9.62 Million USD | 88.92% |
| 2023 Q3 | 1.84 Million USD | 119.11% |
| 2023 Q4 | -9.66 Million USD | -625.16% |
| 2023 Q1 | -86.93 Million USD | 64.32% |
| 2023 FY | -105.14 Million USD | 68.83% |
| 2022 Q3 | -3.72 Million USD | 44.06% |
| 2022 Q1 | -83.41 Million USD | -989.05% |
| 2022 Q2 | -6.66 Million USD | 92.01% |
| 2022 FY | -337.26 Million USD | -3195.57% |
| 2022 Q4 | -243.63 Million USD | -6435.17% |
| 2021 Q1 | -366 Thousand USD | 79.58% |
| 2021 Q3 | -2.26 Million USD | -213.28% |
| 2021 FY | 10.89 Million USD | 332.55% |
| 2021 Q4 | 9.38 Million USD | 514.22% |
| 2021 Q2 | -723 Thousand USD | -97.54% |
| 2020 Q1 | -1.42 Million USD | -591.72% |
| 2020 Q4 | -1.79 Million USD | -103.87% |
| 2020 Q3 | -879 Thousand USD | -49.49% |
| 2020 FY | -4.68 Million USD | -493.04% |
| 2020 Q2 | -588 Thousand USD | 58.77% |
| 2019 Q1 | -85 Thousand USD | 57.5% |
| 2019 Q4 | 290 Thousand USD | 168.08% |
| 2019 FY | -790 Thousand USD | -307.22% |
| 2019 Q3 | -426 Thousand USD | 25.13% |
| 2019 Q2 | -569 Thousand USD | -569.41% |
| 2018 Q3 | -75 Thousand USD | -236.36% |
| 2018 Q1 | 26 Thousand USD | -88.65% |
| 2018 FY | -194 Thousand USD | -121.95% |
| 2018 Q4 | -200 Thousand USD | -166.67% |
| 2018 Q2 | 55 Thousand USD | 111.54% |
| 2017 Q3 | 221 Thousand USD | -47.0% |
| 2017 Q1 | 17 Thousand USD | 100.83% |
| 2017 FY | 884 Thousand USD | 127.37% |
| 2017 Q2 | 417 Thousand USD | 2352.94% |
| 2017 Q4 | 229 Thousand USD | 3.62% |
| 2016 FY | -3.23 Million USD | -396.6% |
| 2016 Q2 | -254 Thousand USD | 49.8% |
| 2016 Q1 | -506 Thousand USD | 29.82% |
| 2016 Q3 | -433 Thousand USD | -70.47% |
| 2016 Q4 | -2.03 Million USD | -370.44% |
| 2015 Q1 | 182 Thousand USD | 145.05% |
| 2015 Q2 | 150 Thousand USD | -17.58% |
| 2015 Q3 | 1.47 Million USD | 885.33% |
| 2015 Q4 | -721 Thousand USD | -148.78% |
| 2015 FY | 1.08 Million USD | 201.78% |
| 2014 FY | -1.07 Million USD | -238.42% |
| 2014 Q4 | -404 Thousand USD | -287.91% |
| 2014 Q3 | 215 Thousand USD | 198.17% |
| 2014 Q2 | -219 Thousand USD | 66.92% |
| 2014 Q1 | -662 Thousand USD | -362.7% |
| 2013 FY | 773 Thousand USD | 112.1% |
| 2013 Q4 | 252 Thousand USD | -56.25% |
| 2013 Q3 | 576 Thousand USD | 440.83% |
| 2013 Q2 | -169 Thousand USD | -221.58% |
| 2013 Q1 | 139 Thousand USD | 106.01% |
| 2012 Q1 | -1.49 Million USD | -123.2% |
| 2012 Q3 | -704 Thousand USD | 62.63% |
| 2012 FY | -6.39 Million USD | -1276.8% |
| 2012 Q2 | -1.88 Million USD | -26.36% |
| 2012 Q4 | -2.31 Million USD | -228.27% |
| 2011 Q2 | 483 Thousand USD | 55.81% |
| 2011 Q4 | -668 Thousand USD | -259.81% |
| 2011 Q1 | 310 Thousand USD | 210.71% |
| 2011 FY | 543 Thousand USD | 120.18% |
| 2011 Q3 | 418 Thousand USD | -13.46% |
| 2010 Q1 | -1.48 Million USD | -5.08% |
| 2010 Q2 | -1.21 Million USD | 18.55% |
| 2010 Q3 | 288 Thousand USD | 123.76% |
| 2010 FY | -2.69 Million USD | 50.74% |
| 2010 Q4 | -280 Thousand USD | -197.22% |
| 2009 Q4 | -1.41 Million USD | -124.05% |
| 2009 FY | -5.46 Million USD | -266.89% |
| 2009 Q1 | -1.58 Million USD | -46.26% |
| 2009 Q2 | -1.83 Million USD | -15.59% |
| 2009 Q3 | -632 Thousand USD | 65.48% |
| 2008 Q3 | -254 Thousand USD | -86.76% |
| 2008 Q4 | -1.08 Million USD | -326.38% |
| 2008 Q1 | -16 Thousand USD | 92.12% |
| 2008 Q2 | -136 Thousand USD | -750.0% |
| 2008 FY | -1.48 Million USD | -260.8% |
| 2007 Q2 | 124 Thousand USD | -77.7% |
| 2007 Q4 | -203 Thousand USD | -145.21% |
| 2007 Q3 | 449 Thousand USD | 262.1% |
| 2007 FY | 926 Thousand USD | 135.48% |
| 2007 Q1 | 556 Thousand USD | 173.45% |
| 2006 Q1 | -716 Thousand USD | -2088.78% |
| 2006 Q2 | 538 Thousand USD | 175.14% |
| 2006 Q3 | -1.67 Million USD | -411.34% |
| 2006 Q4 | -756.94 Thousand USD | 54.81% |
| 2006 FY | -2.6 Million USD | -2484.15% |
| 2005 Q1 | 404 Thousand USD | 297.07% |
| 2005 Q2 | -896 Thousand USD | -321.78% |
| 2005 Q3 | 356 Thousand USD | 139.73% |
| 2005 Q4 | 36 Thousand USD | -89.89% |
| 2005 FY | -100.99 Thousand USD | 50.25% |
| 2004 Q3 | 635 Thousand USD | 226.24% |
| 2004 Q1 | -130 Thousand USD | 65.31% |
| 2004 FY | -203 Thousand USD | -332.52% |
| 2004 Q4 | -205 Thousand USD | -132.28% |
| 2004 Q2 | -503 Thousand USD | -286.92% |
| 2003 Q2 | -167 Thousand USD | -160.73% |
| 2003 Q1 | 275 Thousand USD | 1314.25% |
| 2003 FY | 87.3 Thousand USD | -91.81% |
| 2003 Q4 | -374.69 Thousand USD | -205.85% |
| 2003 Q3 | 354 Thousand USD | 311.98% |
| 2002 Q3 | 281 Thousand USD | -45.86% |
| 2002 Q4 | 19.44 Thousand USD | -93.08% |
| 2002 FY | 1.06 Million USD | -39.64% |
| 2002 Q2 | 519 Thousand USD | 110.12% |
| 2002 Q1 | 247 Thousand USD | -47.97% |
| 2001 Q4 | 474.75 Thousand USD | -7.81% |
| 2001 FY | 1.76 Million USD | 227.84% |
| 2001 Q3 | 515 Thousand USD | -11.51% |
| 2001 Q2 | 582 Thousand USD | 198.46% |
| 2001 Q1 | 195 Thousand USD | 143.92% |
| 2000 Q4 | -444.01 Thousand USD | -219.43% |
| 2000 Q2 | -427 Thousand USD | -6.75% |
| 2000 Q1 | -400 Thousand USD | -233.33% |
| 2000 Q3 | -139 Thousand USD | 67.45% |
| 2000 FY | -1.38 Million USD | -330.34% |
| 1999 Q3 | 100 Thousand USD | -50.0% |
| 1999 Q2 | 200 Thousand USD | 0.0% |
| 1999 Q1 | - USD | 100.0% |
| 1999 FY | 600 Thousand USD | 50.0% |
| 1999 Q4 | 300 Thousand USD | 200.0% |
| 1998 Q4 | -200 Thousand USD | -300.0% |
| 1998 Q1 | 200 Thousand USD | 1900.0% |
| 1998 Q2 | 200 Thousand USD | 0.0% |
| 1998 FY | 400 Thousand USD | -42.86% |
| 1998 Q3 | 100 Thousand USD | -50.0% |
| 1997 FY | 700 Thousand USD | 0.0% |
| 1997 Q4 | 10 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 54.777% |
| Prenetics Global Limited | -62.72 Million USD | -67.624% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -6691.99% |
| CareDx, Inc | -190.28 Million USD | 44.746% |
| Exact Sciences Corporation | -204.14 Million USD | 48.498% |
| Exagen Inc. | -23.68 Million USD | -343.835% |
| Guardant Health, Inc. | -479.44 Million USD | 78.071% |
| Biodesix, Inc. | -52.14 Million USD | -101.626% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -3899.174% |
| Precipio, Inc. | -5.85 Million USD | -1696.344% |
| iSpecimen Inc. | -11.09 Million USD | -847.251% |
| Natera, Inc. | -434.8 Million USD | 75.819% |
| Aspira Women's Health Inc. | -16.69 Million USD | -529.958% |
| Standard BioTools Inc. | -74.65 Million USD | -40.833% |
| 23andMe Holding Co. | -666.7 Million USD | 84.23% |
| Castle Biosciences, Inc. | -57.46 Million USD | -82.96% |
| Personalis, Inc. | -108.29 Million USD | 2.914% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | -18.828% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -956.996% |
| OpGen, Inc. | -32.66 Million USD | -221.839% |
| T2 Biosystems, Inc. | -50.07 Million USD | -109.957% |
| Myriad Genetics, Inc. | -112 Million USD | 6.125% |
| ICON Public Limited Company | 612.33 Million USD | 117.17% |
| NeoGenomics, Inc. | -87.96 Million USD | -19.521% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -6691.99% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 112.442% |
| RadNet, Inc. | 3.04 Million USD | 3554.008% |
| MDxHealth SA | -43.1 Million USD | -143.944% |
| Psychemedics Corporation | -4.15 Million USD | -2431.054% |
| Illumina, Inc. | -1.16 Billion USD | 90.944% |
| Check-Cap Ltd. | -17.56 Million USD | -498.474% |
| Twist Bioscience Corporation | -208.72 Million USD | 49.628% |
| DarioHealth Corp. | -59.42 Million USD | -76.923% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 37.351% |
| Sera Prognostics, Inc. | -36.24 Million USD | -190.105% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -945.103% |
| OPKO Health, Inc. | -188.86 Million USD | 44.33% |
| Medpace Holdings, Inc. | 282.81 Million USD | 137.177% |
| Neogen Corporation | -9.42 Million USD | -1016.017% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -935.173% |
| Prenetics Global Limited | -62.72 Million USD | -67.624% |
| Mainz Biomed B.V. | -26.29 Million USD | -299.837% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -1224.68% |
| Trinity Biotech plc | -24.01 Million USD | -337.755% |
| Neuronetics, Inc. | -30.18 Million USD | -248.273% |
| Sotera Health Company | 51.37 Million USD | 304.648% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -1224.68% |